The Taiwanese Association of Diabetes Educators, with the Taiwanese Osteoporosis Association and the Endocrine Society of the Republic of China, has published a joint consensus on managing osteoporosis in people with diabetes. It is a synthesis of existing guidance rather than new evidence, but it is directed at a gap that guidelines usually leave open.
The central claim is one worth carrying into clinic: diabetes raises fragility fracture risk through altered bone microarchitecture and increased falls, and it does so largely independently of bone mineral density. A reassuring DXA result in a person with long-standing diabetes is therefore weaker evidence of safety than the same result in someone without it, and the consensus asks for fracture risk to be assessed on the whole clinical picture rather than on the T-score alone.
For an Indian practice this lands on a large group: long-duration type 2 diabetes, often with neuropathy and postural instability, in people who are rarely referred for fracture-risk assessment at all. The practical change is not a new drug but a lower threshold for asking the question.
- Diabetes contributes to skeletal fragility through bone microarchitecture and fall risk, not through bone density alone.
- A normal or reassuring DXA does not exclude elevated fracture risk in long-standing diabetes.
- The document is a consensus synthesis from three Taiwanese societies, not a trial.
Why it matters
Fracture risk is rarely assessed at all in diabetes clinics, and the one test most likely to be ordered is the one this consensus says will under-read the risk.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for diabetes & endocrinology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free